{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:39:18Z","timestamp":1758476358774},"reference-count":15,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Thyrotoxic periodic paralysis (TPP) is a life-threatening neuromuscular complication of thyrotoxicosis characterized by muscle weakness and hypokalemia and with an unclear etiopathogenesis. However, the 17q24.3 locus had been genetically linked to TPP, in which the genetic variant rs312691 (TC genotype) in long intergenic noncoding RNA (lincRNA) CTD-2378E21.1 is located downstream of inward-rectifier potassium (Kir) channel genes [KCNJ2 and its antisense KCNJ2 (AS-KCNJ2)]. A TPP patient with a suppressed thyroid-stimulating hormone level, a high free thyroxine level of (5.8 ng\/dL), and low serum potassium level of (2 mEq\/L) was evaluated for Kir channel expression during and after recovery from thyrotoxicosis. We observed that circulating lincRNA and Kir expression varied in accordance with thyroid status and TC genotype. To endorse this association of a lincRNA-rs312691 variant with a genetic risk of TPP, an additional series of 37 patients with TPP and 32 patients with thyrotoxic without paralysis (TWP) were assessed. We verified that the risk of minor allele C was greater in TPP than in TWP (odds ratio, 5.289; P = 0.0062), and protective major allele T was more frequent than observed in the 1000 genome controls (odds ratio, 11.90; P &amp;lt; 0.0001). AS-KCNJ2 was downregulated during thyrotoxicosis in the TWP controls carrying allele T and were upregulated in those with TPP with risk allele C. Moreover, KCNJ2 (Kir2.1) expression was reduced during thyrotoxicosis and restored in euthyroid status. We further excluded any other coding variant by performing targeted exome sequencing mutational screening in 17q24.3. Our data suggest that high lincRNA AS-KCNJ2 and CDT-2378E21.1 expression, possibly driven by the triiodothyronine regulatory mechanism, reduces the Kir2.1 expression observed during thyrotoxicosis. This finding could contribute to the understanding of the reduced inward-rectifying current observed during muscle weakness in genetically susceptible TPP patients.<\/jats:p>","DOI":"10.1210\/js.2017-00015","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T18:50:39Z","timestamp":1493923839000},"page":"809-815","source":"Crossref","is-referenced-by-count":6,"title":["Novel lincRNA Susceptibility Gene and Its Role in Etiopathogenesis of Thyrotoxic Periodic Paralysis"],"prefix":"10.1210","volume":"1","author":[{"given":"Maria Clara C.","family":"Melo","sequence":"first","affiliation":[{"name":"Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04039-032, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana\u00edna S.","family":"de Souza","sequence":"additional","affiliation":[{"name":"Biological Sciences, Universidade Federal de S\u00e3o Paulo, Diadema, 09972-270, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina M. L.","family":"Kizys","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04039-032, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela C.","family":"Vidi","sequence":"additional","affiliation":[{"name":"Molecular Biology Program, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04044-020, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haron S.","family":"Dorta","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04039-032, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilda S.","family":"Kunii","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04039-032, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisele","family":"Giannocco","sequence":"additional","affiliation":[{"name":"Molecular Biology Program, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04044-020, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianna","family":"Carvalheira","sequence":"additional","affiliation":[{"name":"Morphology and Genetics, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04039-032, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus R.","family":"Dias-da-Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular and Translational Endocrinology, Department of Medicine, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, 04039-032, Brazil"},{"name":"Biological Sciences, Universidade Federal de S\u00e3o Paulo, Diadema, 09972-270, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","published-online":{"date-parts":[[2017,2,28]]},"reference":[{"issue":"4","key":"2020071620551754100_B1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0735-6757(03)00037-8","article-title":"Diagnosing thyrotoxic periodic paralysis in the ED","volume":"21","author":"Lin","year":"2003","journal-title":"Am J Emerg Med"},{"issue":"7","key":"2020071620551754100_B2","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2006-0356","article-title":"Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge","volume":"91","author":"Kung","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2020071620551754100_B3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrendo.2011.58","article-title":"Novel etiopathophysiological aspects of thyrotoxic periodic paralysis","volume":"7","author":"Maciel","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2020071620551754100_B4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","article-title":"Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis","volume":"140","author":"Ryan","year":"2010","journal-title":"Cell"},{"issue":"5","key":"2020071620551754100_B5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/jhg.2012.20","article-title":"A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis","volume":"57","author":"Jongjaroenprasert","year":"2012","journal-title":"J Hum Genet"},{"issue":"9","key":"2020071620551754100_B6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/ng.2367","article-title":"Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3","volume":"44","author":"Cheung","year":"2012","journal-title":"Nat Genet"},{"key":"2020071620551754100_B7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cca.2012.08.004","article-title":"Genetic variant rs623011 (17q24.3) associates with non-familial thyrotoxic and sporadic hypokalemic paralysis","volume":"414","author":"Chu","year":"2012","journal-title":"Clin Chim Acta"},{"key":"2020071620551754100_B8"},{"issue":"4","key":"2020071620551754100_B9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00438-016-1185-0","article-title":"Whole genome and exome sequencing realignment supports the assignment of KCNJ12, KCNJ17, and KCNJ18 paralogous genes in thyrotoxic periodic paralysis locus: functional characterization of two polymorphic Kir2.6 isoforms","volume":"291","author":"Paninka","year":"2016","journal-title":"Mol Genet Genomics"},{"key":"2020071620551754100_B10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6750-7-21","article-title":"Potential pitfalls in the accuracy of analysis of natural sense-antisense RNA pairs by reverse transcription-PCR","volume":"7","author":"Haddad","year":"2007","journal-title":"BMC Biotechnol"},{"issue":"13","key":"2020071620551754100_B11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1212\/WNL.0000000000002524","article-title":"Novel susceptibility gene for nonfamilial hypokalemic periodic paralysis","volume":"86","author":"Song","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"2020071620551754100_B12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/mus.21693","article-title":"INa and IKir are reduced in type 1 hypokalemic and thyrotoxic periodic paralysis","volume":"42","author":"Puwanant","year":"2010","journal-title":"Muscle Nerve"},{"key":"2020071620551754100_B13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neuroscience.2017.01.019","article-title":"Down-regulation of Kir2.6 channel by c-termini mutation D252N and its association with the susceptibility to thyrotoxic periodic paralysis","volume":"346","author":"Paninka","year":"2017","journal-title":"Neuroscience"},{"issue":"8","key":"2020071620551754100_B14","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.7314\/APJCP.2015.16.8.3355","article-title":"Expression profile analysis of zinc transporters (ZIP4, ZIP9, ZIP11, ZnT9) in gliomas and their correlation with IDH1 mutation status","volume":"16","author":"Kang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"issue":"10","key":"2020071620551754100_B15","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1007\/s13277-015-3459-2","article-title":"Zinc transporter genes and urological cancers: integrated analysis suggests a role for ZIP11 in bladder cancer","volume":"36","author":"Wu","year":"2015","journal-title":"Tumour Biol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/1\/7\/809\/17856241\/js.2017-00015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/1\/7\/809\/17856241\/js.2017-00015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T05:48:09Z","timestamp":1594964889000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/1\/7\/809\/3058129"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/js.2017-00015","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,7,1]]},"published":{"date-parts":[[2017,2,28]]}}}